Amphastar Pharmaceuticals Inc

NASDAQ:AMPH   3:59:43 PM EDT
20.66
-0.16 (-0.77%)
Products

Amphastar Pharmaceuticals Receives FDA Approval For Atropine Sulfate Injection

Published: 10/06/2020 10:11 GMT
Amphastar Pharmaceuticals Inc (AMPH) - Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection.
Amphastar Pharmaceuticals Inc - Net Revenues for Company's Atropine Sulfate Injection for Year Ended December 31, 2019 Were $12.2 Million.
Amphastar Pharmaceuticals - FDA Approved Anda for Atropine Sulfate Injection 0.1mg/ml in 10 Ml Luer-jet Prefilled Syringe System.